Growth Metrics

Biomerica (BMRA) Accumulated Expenses (2011 - 2026)

Biomerica recorded quarterly Accumulated Expenses of $608000.0 in Q1 2026, up 11.56% quarter-over-quarter from $545000.0 in Q4 2025, and down 0.65% year-over-year from $612000.0 in Q1 2025.

Biomerica's Accumulated Expenses history runs 16 years deep, the most recent figure standing at $608000.0 for Q1 2026.

  • In Q1 2026, Accumulated Expenses fell 0.65% year-over-year to $608000.0; the TTM figure through Feb 2026 stood at $608000.0 (down 0.65% YoY), while the FY2025 annual figure was $655000.0, up 13.32% from the prior year.
  • Accumulated Expenses came in at $608000.0 for Q1 2026 at Biomerica, up from $545000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $702000.0 in Q1 2024 to a low of $236000.0 in Q2 2022.
  • A 5-year average of $588286.4 and a median of $601000.0 in 2024 frame the typical range for Accumulated Expenses.
  • Across the five-year window, Accumulated Expenses surged 132.2% in 2023 and retreated 12.82% in 2025, its largest moves.
  • Biomerica's Accumulated Expenses stood at $697179.0 in 2022, then decreased by 4.19% to $668000.0 in 2023, then fell by 10.03% to $601000.0 in 2024, then fell by 9.32% to $545000.0 in 2025, then climbed by 11.56% to $608000.0 in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $608000.0, $545000.0, and $591000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Biomerica 7.12 Mn 5.78 Mn -44,000.00

Historic Data

Download Data 🔒
DateValue
Feb 28, 2026 608,000.00
Nov 30, 2025 545,000.00
Aug 31, 2025 591,000.00
May 31, 2025 655,000.00
Feb 28, 2025 612,000.00
Nov 30, 2024 601,000.00
Aug 31, 2024 643,000.00
May 31, 2024 578,000.00
Feb 29, 2024 702,000.00
Nov 30, 2023 668,000.00
Aug 31, 2023 667,000.00
May 31, 2023 548,000.00
Feb 28, 2023 520,457.00
Nov 30, 2022 697,179.00
Aug 31, 2022 591,948.00
May 31, 2022 236,000.00
Feb 28, 2022 537,284.00
Nov 30, 2021 674,327.00
Aug 31, 2021 507,722.00
May 31, 2021 152,000.00
Feb 28, 2021 366,936.00
Nov 30, 2020 392,006.00
Aug 31, 2020 309,345.00
May 31, 2020 278,627.00
Feb 29, 2020 236,043.00
Nov 30, 2019 239,072.00
Aug 31, 2019 230,145.00
May 31, 2019 226,829.00
Feb 28, 2019 223,754.00
Nov 30, 2018 216,280.00
Aug 31, 2018 214,556.00
May 31, 2018 209,852.00
Aug 31, 2017 186,676.00
May 31, 2017 176,866.00
Feb 28, 2017 164,070.00
Nov 30, 2016 195,461.00
Aug 31, 2016 181,737.00
May 31, 2016 172,542.00
Feb 29, 2016 159,834.00
Nov 30, 2015 153,253.00
Aug 31, 2015 133,820.00
May 31, 2015 131,794.00
Feb 28, 2015 130,425.00
Nov 30, 2014 47,641.00
Aug 31, 2014 118,281.00
May 31, 2014 114,163.00
Feb 28, 2014 120,322.00
Nov 30, 2013 120,618.00
Aug 31, 2013 40,543.00
May 31, 2013 207,976.00
Feb 28, 2013 100,411.00
Nov 30, 2012 34,147.00
Aug 31, 2012 258,888.00
May 31, 2012 186,841.00
Feb 29, 2012 185,555.00
Nov 30, 2011 144,288.00
Aug 31, 2011 111,876.00
May 31, 2011 138,056.00